Proteinases as virulence factors in Leishmania spp. infection in mammals

被引:0
作者
Mariana Silva-Almeida
Bernardo Acácio Santini Pereira
Michelle Lopes Ribeiro-Guimarães
Carlos Roberto Alves
机构
[1] IOC,Laboratório de Biologia Molecular e Doenças Endêmicas
[2] Fiocruz,undefined
来源
Parasites & Vectors | / 5卷
关键词
spp.; Leishmaniasis; Protease; Proteinase; Lesion;
D O I
暂无
中图分类号
学科分类号
摘要
Leishmania parasites cause human tegumentary and visceral infections that are commonly referred to as leishmaniasis. Despite the high incidence and prevalence of cases, leishmaniasis has been a neglected disease because it mainly affects developing countries. The data obtained from the analysis of patients’ biological samples and from assays with animal models confirm the involvement of an array of the parasite’s components in its survival inside the mammalian host. These components are classified as virulence factors. In this review, we focus on studies that have explored the role of proteinases as virulence factors that promote parasite survival and immune modulation in the mammalian host. Additionally, the direct involvement of proteinases from the host in lesion evolution is analyzed. The gathered data shows that both parasite and host proteinases are involved in the clinical manifestation of leishmaniasis. It is interesting to note that although the majority of the classes of proteinases are present in Leishmania spp., only cysteine-proteinases, metalloproteinases and, to a lesser scale, serine-proteinases have been adequately studied. Members from these classes have been implicated in tissue invasion, survival in macrophages and immune modulation by parasites. This review reinforces the importance of the parasite proteinases, which are interesting candidates for new chemo or immunotherapies, in the clinical manifestations of leishmaniasis.
引用
收藏
相关论文
共 485 条
[1]  
Stark D(2008)Leishmaniasis, an emerging imported infection: report of 20 cases from Australia J Travel Med 15 351-354
[2]  
van Hal S(2005)The current status of zoonotic leishmaniases and approaches to disease control Int J Parasitol 35 1169-1180
[3]  
Lee R(2004)Leishmaniasis: current situation and new perspectives Comp Immunol Microbiol Infect Dis 27 305-318
[4]  
Marriott D(2010)Leishmaniasis, an emerging infection in travelers Inter J Infect Dis 14 e1032-e1039
[5]  
Harkness J(2004)New insights into the developmental biology and transmission mechanisms of Leishmania Curr Mol Med 4 601-609
[6]  
Gramiccia M(1994)Tegumentary and visceral leishmaniases in Brazil: emerging anthropozoonosis and possibilities for their control Cad Saude Publica 10 359-375
[7]  
Gradoni L(2007)Cutaneous Leishmaniasis Lancet Infect Dis 7 581-596
[8]  
Desjeux P(2003)Migration through the extracellular matrix by the parasitic protozoan Leishmania is enhanced by surface metalloprotease gp63 Infect Immun 71 1008-1010
[9]  
Pavlia A(1997)Leishmania mexicana: binding of promastigotes to type I collagen Exp Parasitol 85 149-157
[10]  
Maltezoub HC(1983)Characterization of the cellular immune response in American cutaneous leishmaniasis Clin Immunol Immunopathol 27 176-186